SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (491)12/30/2018 4:18:19 PM
From: BulbaMan  Respond to of 684
 
Thanks! Will probably pick IMDZ for my Contest portfolio.



To: rkrw who wrote (491)12/30/2018 6:50:12 PM
From: ghmm  Respond to of 684
 
Thanks for the analysis and history!

I got a little lucky on past ones (advm and agtc ). Part of it was they had pipelines and good cash runway...other part was I bailed when the stocks did better and yet the new info (or lack of expected info) out of the companies actually made prospects look worse though in advm case I should have seen it much earlier.

A couple from the list that I'm slightly familiar may be worth closer looks but should likely also keep a quick trigger finger.



To: rkrw who wrote (491)2/21/2019 9:36:34 AM
From: bmaz001  Respond to of 684
 
Merck acquires less-than-cash IMDZ for $5.85/sh.